ESSA Pharma Announces Overnight Marketed Equity Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
ESSA Pharma (EPIX) Prices Equity Offering at $0.20/Share
December 13, 2017 8:57 AM ESTESSA Pharma Inc. (NASDAQ: EPIX), a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, is pleased to announce today that the Company has priced its previously announced offering of equity securities (the "Offering"). Pursuant to the Offering, ESSA intends to issue common shares in the capital of the Company (the "Common Shares") at a price of US$0.20 per Common Share (the "Common Share Price").
The Offering will be undertaken on a best efforts basis pursuant to the terms and... More
ESSA Pharma (EPIX) Halted, News Pending
December 13, 2017 8:52 AM ESTESSA Pharma (NASDAQ: EPIX) Halted, News Pending
... More


